PubMed

Whole-body 18 FDG PET/CT imaging for lymph node and metastatic staging of conjunctival melanoma.

Kurli M, Chin K, Finger PT.

Br J Ophthalmol. 2008 Apr;92(4):479-82.PMID: 18369064 [PubMed - indexed for MEDLINE]Related articles

Whole body PET/CT for initial staging of choroidal melanoma.

Finger PT, Kurli M, Reddy S, Tena LB, Pavlick AC.

Br J Ophthalmol. 2005 Oct;89(10):1270-4.PMID: 16170114 [PubMed - indexed for MEDLINE]Related articlesFree article

Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.

Kurli M, Reddy S, Tena LB, Pavlick AC, Finger PT.

Am J Ophthalmol. 2005 Aug;140(2):193-9.PMID: 15992753 [PubMed - indexed for MEDLINE]Related articles

Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.

Wagner JD, Schauwecker D, Davidson D, Logan T, Coleman JJ 3rd, Hutchins G, Love C, Wenck S, Daggy J.

Cancer. 2005 Aug 1;104(3):570-9.PMID: 15977211 [PubMed - indexed for MEDLINE]Related articlesFree article

Staging of colon cancer: whole-body MRI vs. whole-body PET-CT--initial clinical experience.

Squillaci E, Manenti G, Mancino S, Cicciò C, Calabria F, Danieli R, Schillaci O, Simonetti G.

Abdom Imaging. 2008 Nov-Dec;33(6):676-88.PMID: 18373114 [PubMed - indexed for MEDLINE]Related articles

Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy.

Wagner JD, Schauwecker D, Davidson D, Coleman JJ 3rd, Saxman S, Hutchins G, Love C, Hayes JT.

J Clin Oncol. 1999 May;17(5):1508-15.PMID: 10334538 [PubMed - indexed for MEDLINE]Related articles

Role of FDG-PET in the assessment of survival prognosis in melanoma.

Pleiss C, Risse JH, Biersack HJ, Bender H.

Cancer Biother Radiopharm. 2007 Dec;22(6):740-7.PMID: 18158764 [PubMed - indexed for MEDLINE]Related articles

Positron emission tomography using 18F-fluorodeoxyglucose in advanced stages of malignant melanoma: a comparison of ultrasonographic and radiological methods of diagnosis.

Dietlein M, Krug B, Groth W, Smolarz K, Scheidhauer K, Psaras T, Stützer H, Lackner K, Schicha H.

Nucl Med Commun. 1999 Mar;20(3):255-61.PMID: 10093075 [PubMed - indexed for MEDLINE]Related articles

High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases.

Strobel K, Dummer R, Husarik DB, Pérez Lago M, Hany TF, Steinert HC.

Radiology. 2007 Aug;244(2):566-74.PMID: 17641374 [PubMed - indexed for MEDLINE]Related articlesFree article

[F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.

Jadvar H, Henderson RW, Conti PS.

J Comput Assist Tomogr. 2007 Mar-Apr;31(2):223-8.PMID: 17414758 [PubMed - indexed for MEDLINE]Related articles

Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer.

Gearhart SL, Frassica D, Rosen R, Choti M, Schulick R, Wahl R.

Ann Surg Oncol. 2006 Mar;13(3):397-404. Epub 2006 Jan 30.PMID: 16485158 [PubMed - indexed for MEDLINE]Related articles

Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients.

Reinhardt MJ, Joe AY, Jaeger U, Huber A, Matthies A, Bucerius J, Roedel R, Strunk H, Bieber T, Biersack HJ, Tüting T.

J Clin Oncol. 2006 Mar 1;24(7):1178-87.PMID: 16505438 [PubMed - indexed for MEDLINE]Related articles

Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?

Casneuf V, Delrue L, Kelles A, Van Damme N, Van Huysse J, Berrevoet F, De Vos M, Duyck P, Peeters M.

Acta Gastroenterol Belg. 2007 Oct-Dec;70(4):331-8.PMID: 18330088 [PubMed - indexed for MEDLINE]Related articles

Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer.

Ueda S, Tsuda H, Asakawa H, Omata J, Fukatsu K, Kondo N, Kondo T, Hama Y, Tamura K, Ishida J, Abe Y, Mochizuki H.

BMC Cancer. 2008 Jun 9;8:165.PMID: 18541009 [PubMed - indexed for MEDLINE]Related articlesFree article

The role of fluorine-18 deoxyglucose positron emission tomography in the management of patients with metastatic melanoma: impact on surgical decision making.

Gulec SA, Faries MB, Lee CC, Kirgan D, Glass C, Morton DL, Essner R.

Clin Nucl Med. 2003 Dec;28(12):961-5.PMID: 14663316 [PubMed - indexed for MEDLINE]Related articles

Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma.

Clark PB, Soo V, Kraas J, Shen P, Levine EA.

Arch Surg. 2006 Mar;141(3):284-8.PMID: 16549694 [PubMed - indexed for MEDLINE]Related articlesFree article

Second cancers discovered by (18)FDG PET/CT imaging for choroidal melanoma.

Chin K, Finger PT, Kurli M, Tena LB, Reddy S.

Optometry. 2007 Aug;78(8):396-401.PMID: 17662928 [PubMed - indexed for MEDLINE]Related articles

Staging of regional nodes in AJCC stage I and II melanoma: 18FDG PET imaging versus sentinel node detection.

Belhocine T, Pierard G, De Labrassinne M, Lahaye T, Rigo P.

Oncologist. 2002;7(4):271-8.PMID: 12185291 [PubMed - indexed for MEDLINE]Related articlesFree article

Fluor-18-fluorodeoxyglucose positron emission tomography (FDG-PET) in malignant melanoma. Diagnostic comparison with conventional imaging methods.

Krug B, Dietlein M, Groth W, Stützer H, Psaras T, Gossmann A, Scheidhauer K, Schicha H, Lackner K.

Acta Radiol. 2000 Sep;41(5):446-52.PMID: 11016764 [PubMed - indexed for MEDLINE]Related articles

FDG-PET for preoperative staging of bladder cancer.

Drieskens O, Oyen R, Van Poppel H, Vankan Y, Flamen P, Mortelmans L.

Eur J Nucl Med Mol Imaging. 2005 Dec;32(12):1412-7. Epub 2005 Aug 31.PMID: 16133380 [PubMed - indexed for MEDLINE]Related articles